Global Antidiuretic Drugs Market Size, Share and Trends Analysis Report, By Type (Vasopressin, Desmopressin, Oxytocin, and Others), By Application (Diabetes Insipidus, Hemophilia, Hypertension, and Others), Forecast (2022-2028)

The global antidiuretic drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). An antidiuretic substance aids in the regulation of fluid balance in the body. The rising prevalence of diabetes and other chronic diseases such as cardiovascular disease, as well as the increasing use of antidiuretic drugs for the treatment of hemophilia and a large patient pool with hypertension, are driving the growth of the antidiuretic drug markets. According to the data published by World Health Organization in 2021, cardiovascular diseases are the leading causes of death globally. Approximately, 17.9 million mortalities occurred due to cardiovascular diseases in 2019, representing 32.0% of all global fatalities. Out of these, 85.0% were due to heart attack and stroke. Moreover, 17 million premature mortalities occurred due to non-communicable diseases, out of which 38.0% were caused by cardiovascular diseases. Thus, the rise in the prevalence of cardiovascular diseases is anticipated to fuel the demand for antideuretic drugs during the forecast period.

The popularity of desmopressin analogues has also created numerous growth opportunities in the global antidiuretic drug market. The rising prevalence of genitourinary disorders, particularly among the elderly, has fueled the growth of the global antidiuretic drugs market. It is expected that advancements in urologic care and treatment will also fuel the growth of the global antidiuretic drugs market.The high cost of the drug, stringent regulatory scenarios in drug development, and risk factors associated with antidiuretics such as excessive bleeding, lightheadedness, and hematoma during blood sample collection from diuretics users are expected to restrain the antidiuretics market during the forecast period.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Azevan Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Ltd., Otsuka Holdings Co., Ltd., Taj Pharmaceuticals Limited, Novartis AG, F.Hoffmann-La Roche., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Antidiuretic Drugs Market Report by Segment

By Type

• Vasopressin
• Desmopressin
• Oxytocin
• Others

By Application

• Diabetes Insipidus
• Hemophilia
• Hypertension
• Others

Global Antidiuretic Drugs Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa